NXThera Inc.
![]() |
NXThera, Inc. is developing a minimally invasive treatment for enlarged prostate and prostate cancer. 7351 Kirkwood Lane N Suite 138 Maple Grove, MN 55369 (763) 515-0404 Back to Portfolio |
Esperion Therapeutics Announces Positive Top-Line Results from Phase 2 Clinical Study
Fidelis SeniorCare Closes $20.5 Million Equity Financing
Tangent Medical Named Finalist in 2013 American Business Awards
IntelliCyt Corporation Closes $8 Million in New Financing
Esperion Therapeutics Presents Full Results of Phase 2 Clinical Trial
As Companies Abandon Cholesterol, an Old Player Re-Emerges
Esperion Therapeutics Completes $33 Million Preferred Financing
BAROnova Announces the Results of ENDObesity I Clinical Trial
Advanced ICU Care: A Prescription for Strapped Hospitals
Amerigroup Maryland Members Increase Use of Wellness Services Through MyHealthDIRECT


